In conclusion, our study supports the notion that as an initial step in IPF, the senescence process in AECs may be a potential therapeutic target, and the PTEN/NF‐κB pathway may be a promising candidate for intervention. This evidence concerns the gene NFKB1 and idiopathic pulmonary fibrosis.